Effects of BCG on lysozyme and “active” T cells in patients with malignant melanoma: A preliminary study
- 1 February 1979
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 12 (2), 191-203
- https://doi.org/10.1016/0090-1229(79)90008-4
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cellsInternational Journal of Cancer, 1977
- LEVAMISOLE IN WISKOTT-ALDRICH SYNDROMEThe Lancet, 1976
- The “active” rosette test in immunodeficiency diseasesClinical Immunology and Immunopathology, 1975
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974
- Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation of BCG: Correlation with cell-mediated immunityInternational Journal of Cancer, 1974
- THE MODIFYING EFFECT OF BCG ON THE IMMUNOLOGICAL INDUCTION OF T CELLSThe Journal of Experimental Medicine, 1974
- IN VITRO SYNTHESIS AND SECRETION OF LYSOZYME BY MONONUCLEAR PHAGOCYTESThe Journal of Experimental Medicine, 1974
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Immunological Factors in Human Sarcomas and MelanomasAnnals of Surgery, 1970
- SERUM AND URINARY LYSOZYME (MURAMIDASE) IN MONOCYTIC AND MONOMYELOCYTIC LEUKEMIAThe Journal of Experimental Medicine, 1966